Skip to main content
Erschienen in: World Journal of Surgery 5/2009

01.05.2009

Excellent Prognosis of Patients with Nonhereditary Medullary Thyroid Carcinoma with Ultrasonographic Findings of Follicular Tumor or Benign Nodule

verfasst von: Mitsuhiro Fukushima, Yasuhiro Ito, Mitsuyoshi Hirokawa, Akihiro Miya, Kaoru Kobayashi, Haruki Akasu, Kazuo Shimizu, Akira Miyauchi

Erschienen in: World Journal of Surgery | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Medullary thyroid carcinoma (MTC) accounts for only 1.4% of all thyroid malignancies in Japan. Generally, MTC shows ultrasonographic findings typical of thyroid carcinoma. However, in our experience, some MTC may be diagnosed as a follicular tumor or a benign nodule on ultrasonography because ultrasonographic findings of malignancy are lacking. In this study we investigated differences in biological behavior between these two types of MTC.

Methods

Seventy-seven patients with nonhereditary MTC who underwent surgery in our department between 1988 and 2007 were enrolled in this study. Of these patients, 54 were diagnosed as having thyroid carcinoma (malignant, or M-type) but the remaining 23 were diagnosed as having follicular tumor or benign nodule (benign, or B-type) on ultrasonography.

Results

Clinically apparent lateral node metastasis, extrathyroid extension, and extranodal tumor extension were observed in 37%, 17%, and 11% of M-type patients, respectively, but none of the B-type patients showed any of these features. All B-type patients but only 59% of M-type patients were biochemically cured. Lymph node metastasis was pathologically confirmed in 38 and 65% of B-type and M-type patients, respectively. Eight patients showed recurrence and three have died of carcinoma to date; all of these patients were M-type patients.

Conclusions

B-type MTC is highly indolent and shows an excellent prognosis. However, thyroidectomy and lymph node dissection for B-type MTC should be the same as for M-type MTC because 38% of B-type MTC showed pathologic node metastasis.
Literatur
1.
Zurück zum Zitat Ezaki H, Ebihara S, Fujimoto Y et al (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977–1986 with special reference to predominance of papillary type. Cancer 70:808–814PubMedCrossRef Ezaki H, Ebihara S, Fujimoto Y et al (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977–1986 with special reference to predominance of papillary type. Cancer 70:808–814PubMedCrossRef
2.
Zurück zum Zitat Moley JE, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887PubMedCrossRef Moley JE, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887PubMedCrossRef
3.
Zurück zum Zitat Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148PubMedCrossRef Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148PubMedCrossRef
4.
Zurück zum Zitat Gulben K, Berberoglu U, Boyabatl M (2006) Prognostic factors for sporadic medullary thyroid crcinoma. World J Surg 30:84–90PubMedCrossRef Gulben K, Berberoglu U, Boyabatl M (2006) Prognostic factors for sporadic medullary thyroid crcinoma. World J Surg 30:84–90PubMedCrossRef
5.
Zurück zum Zitat DeLellis RA, Rule AH, Spiler I et al (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70:587–594PubMed DeLellis RA, Rule AH, Spiler I et al (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70:587–594PubMed
6.
Zurück zum Zitat Raue R, Kkotzerke J, Reinwein D et al (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin Invest 71:7–12CrossRef Raue R, Kkotzerke J, Reinwein D et al (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin Invest 71:7–12CrossRef
7.
Zurück zum Zitat Mulligan LM, Kwok JB, Healey C et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 2:851–856 Mulligan LM, Kwok JB, Healey C et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 2:851–856
8.
Zurück zum Zitat Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851–856PubMedCrossRef Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851–856PubMedCrossRef
9.
Zurück zum Zitat Carlson KM, Dou S, Chi D et al (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579–1583PubMedCrossRef Carlson KM, Dou S, Chi D et al (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579–1583PubMedCrossRef
10.
Zurück zum Zitat Hyer SL, Newbold K, Harmer C (2005) Familial medullary thyroid cancer: clinical aspects and prognosis. Eur J Surg Oncol 31:415–419PubMedCrossRef Hyer SL, Newbold K, Harmer C (2005) Familial medullary thyroid cancer: clinical aspects and prognosis. Eur J Surg Oncol 31:415–419PubMedCrossRef
11.
Zurück zum Zitat Cupisti K, Wolf A, Raffel A et al (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution’s experience over 20 years. Ann Surg 246:815–821PubMedCrossRef Cupisti K, Wolf A, Raffel A et al (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution’s experience over 20 years. Ann Surg 246:815–821PubMedCrossRef
12.
Zurück zum Zitat Lee NC, Norton JA (2000) Multiple endocrine neoplasia type 2B—genetic basis and clinical expression. Surg Oncol 9:111–118PubMedCrossRef Lee NC, Norton JA (2000) Multiple endocrine neoplasia type 2B—genetic basis and clinical expression. Surg Oncol 9:111–118PubMedCrossRef
13.
Zurück zum Zitat Brauckhoff M, Gimm O, Weiss CL et al (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305–1311PubMedCrossRef Brauckhoff M, Gimm O, Weiss CL et al (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305–1311PubMedCrossRef
14.
Zurück zum Zitat Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138PubMedCrossRef Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138PubMedCrossRef
15.
Zurück zum Zitat Kameyama K, Takami H (2004) Medullary thyroid carcinoma: Nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J 51:453–456PubMedCrossRef Kameyama K, Takami H (2004) Medullary thyroid carcinoma: Nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J 51:453–456PubMedCrossRef
16.
Zurück zum Zitat Ito Y, Amino N, Ota H et al (2007) Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 17:1269–1276PubMedCrossRef Ito Y, Amino N, Ota H et al (2007) Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 17:1269–1276PubMedCrossRef
17.
Zurück zum Zitat Yokozawa T, Fukata S, Kuma K et al (1996) Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J Surg 20(7):848–853; discussion 853PubMedCrossRef Yokozawa T, Fukata S, Kuma K et al (1996) Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J Surg 20(7):848–853; discussion 853PubMedCrossRef
18.
Zurück zum Zitat Papaparaskeva K, Nagel H, Droese M (2000) Cytologic diagnosis of medullary carcinoma of the thyroid. Diagn Cytopathol 22:351–358PubMedCrossRef Papaparaskeva K, Nagel H, Droese M (2000) Cytologic diagnosis of medullary carcinoma of the thyroid. Diagn Cytopathol 22:351–358PubMedCrossRef
19.
Zurück zum Zitat Bugalho MJ, Santos JR, Sobrinho L (2005) Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56–60PubMedCrossRef Bugalho MJ, Santos JR, Sobrinho L (2005) Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56–60PubMedCrossRef
20.
Zurück zum Zitat Kudo T, Miyauchi A, Ito Y et al (2007) Diagnosis of medullary thyroid carcioma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17:635–638PubMedCrossRef Kudo T, Miyauchi A, Ito Y et al (2007) Diagnosis of medullary thyroid carcioma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17:635–638PubMedCrossRef
21.
Zurück zum Zitat Ito Y, Miyauchi A, Yabuta T et al (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: Experience of a single institution. World J Surg 33:58–66PubMedCrossRef Ito Y, Miyauchi A, Yabuta T et al (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: Experience of a single institution. World J Surg 33:58–66PubMedCrossRef
22.
Zurück zum Zitat Gharib H, McConahey WM, Tiegs RD et al (1992) Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clinic Proc 67:934–940 Gharib H, McConahey WM, Tiegs RD et al (1992) Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clinic Proc 67:934–940
23.
Zurück zum Zitat Miyauchi A, Matsuzuka F, Hirai K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372PubMedCrossRef Miyauchi A, Matsuzuka F, Hirai K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372PubMedCrossRef
24.
Zurück zum Zitat Sobin LH, Wittekind CH (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York Sobin LH, Wittekind CH (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
25.
Zurück zum Zitat Saad MF, Ordonez NG, Rashid RK (1984) Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63:319–342PubMedCrossRef Saad MF, Ordonez NG, Rashid RK (1984) Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63:319–342PubMedCrossRef
26.
Zurück zum Zitat Brierley J, Tsang R, Simpson WJ (1996) Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310PubMedCrossRef Brierley J, Tsang R, Simpson WJ (1996) Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310PubMedCrossRef
27.
Zurück zum Zitat Dottorini ME, Assi A, Sironi M (1996) Multivariate analysis of patients with medullary carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565PubMedCrossRef Dottorini ME, Assi A, Sironi M (1996) Multivariate analysis of patients with medullary carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565PubMedCrossRef
28.
Zurück zum Zitat Clark JR, Friedman TR, Odell MJ (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1145–1150CrossRef Clark JR, Friedman TR, Odell MJ (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1145–1150CrossRef
29.
Zurück zum Zitat Machens A, Hofmann C, Hauptmann S et al (2007) Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. Eur J Endocrinol 157:85–93PubMedCrossRef Machens A, Hofmann C, Hauptmann S et al (2007) Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. Eur J Endocrinol 157:85–93PubMedCrossRef
30.
Zurück zum Zitat Schroder S, Bocker W, Baisch H et al (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816PubMedCrossRef Schroder S, Bocker W, Baisch H et al (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816PubMedCrossRef
Metadaten
Titel
Excellent Prognosis of Patients with Nonhereditary Medullary Thyroid Carcinoma with Ultrasonographic Findings of Follicular Tumor or Benign Nodule
verfasst von
Mitsuhiro Fukushima
Yasuhiro Ito
Mitsuyoshi Hirokawa
Akihiro Miya
Kaoru Kobayashi
Haruki Akasu
Kazuo Shimizu
Akira Miyauchi
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 5/2009
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-9939-z

Weitere Artikel der Ausgabe 5/2009

World Journal of Surgery 5/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.